Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy

Eur Urol. 2011 Dec;60(6):1258-65. doi: 10.1016/j.eururo.2011.05.049. Epub 2011 Jun 7.

Abstract

Background: It is not known whether the primary tumour location of upper urinary tract urothelial carcinoma (UUT-UC) is associated with prognosis.

Objective: To evaluate the impact of initial primary tumour location on survival in patients who had undergone radical nephroureterectomy (RNU).

Design, setting, and participants: Using a multi-institutional, retrospective database, we identified 609 patients with UUT-UC who had undergone RNU between 1995 and 2010. Tumour location was categorised as renal pelvis, ureter, or multifocal.

Intervention: All patients had undergone RNU.

Measurements: Tumour location was tested as a prognostic factor for survival through univariate and multivariable Cox regression analysis.

Results and limitations: Tumour location was renal pelvis in 317 cases (52%), ureter in 185 cases (30%), and multifocal in 107 cases (18%). Compared to renal pelvic and ureteral tumours, multifocal tumours were more likely to be associated with advanced stages (pT3/pT4; 39%, 30%, and 54%, respectively; p<0.001) and high-grade disease (53%, 56%, and 76%, respectively; p<0.001). On multivariable analysis, tumour location was an independent prognostic factor for cancer-specific death, disease recurrence, and metastasis (p<0.05). The 5-yr cancer-specific death-free survival probability was 86.8% for renal pelvic tumours, 68.9% for ureteral tumours, and 56.8% for multifocal tumours (p<0.001). The retrospective design of this study was its main limitation.

Conclusions: Ureteral and multifocal tumours had a worse prognosis than renal pelvic tumours. These findings are not in line with recently published data and should be investigated in a prospective assessment to obtain a definitive statement regarding this matter.

Publication types

  • Comparative Study
  • Multicenter Study

MeSH terms

  • Aged
  • Carcinoma / mortality
  • Carcinoma / secondary
  • Carcinoma / surgery*
  • Chi-Square Distribution
  • Disease-Free Survival
  • Female
  • Frankreich
  • Humans
  • Kaplan-Meier Estimate
  • Kidney Neoplasms / mortality
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / surgery*
  • Kidney Pelvis / pathology
  • Kidney Pelvis / surgery*
  • Male
  • Middle Aged
  • Nephrectomy* / adverse effects
  • Nephrectomy* / mortality
  • Proportional Hazards Models
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Survival Rate
  • Time Factors
  • Treatment Outcome
  • Ureteral Neoplasms / mortality
  • Ureteral Neoplasms / pathology
  • Ureteral Neoplasms / surgery*
  • Urothelium / pathology
  • Urothelium / surgery